Leila Jaafar is the founder of Nuclidium. Nuclidium has raised $134M in total funding. Latest round: Series B. Based in Basel, Switzerland.
Dr. Leila Jaafar is the CEO and Founder of Nuclidium AG, a clinical-stage radiopharmaceutical company. She transitioned from academia to found Nuclidium in 2021, focusing on developing copper-based diagnostics and therapeutics for cancer. Her work addresses unmet needs in accurately detecting and staging cancer through copper theranostics.
Full founder directory · Investor directory · Company funding database · Fundraising library